NATCO Pharma Limited (NATCOPHARM.NS) NSE

822.35

+29.4(+3.71%)

Updated at November 12 03:30PM

Currency In INR

Valuation

Market Cap144.18B
Enterprise Value125.22B
P/E Ratio8.68
PEG Ratio-0.87
Price/Sales Ratio3.35
Price/Book Ratio1.93
Enterprise/Revenue3.35
Enterprise/EBITDA7.7

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.39
Operating Margin0.66

Management Effectiveness

Return On Assets0
Return On Equity0.23

Income Statement

Revenue44.32B
Revenue/Share245.58
Gross Profit37.05B
EBITDA21.44B
Net Income18.85B
Diluted EPS105.26

Balance Sheet

Total Cash24.97B
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share425.04

Price History

52-Week Change-40.87
52-Week High1,505
52-Week Low726.8
Moving Average 50 Days832.08
Moving Average 200 Days873.63

Statistics

Average Volume471,593
Shares Outstanding179.11M
% Held by Institutions0.05

Dividend And Splits

Trailing Annual Dividend Rate5
Trailing Annual Dividend Yield0.61
Payout Ratio0
Last Split Factor5:1
Last Split DateNovember 26, 2015